1. Home
  2. RIGL vs HRTX Comparison

RIGL vs HRTX Comparison

Compare RIGL & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • HRTX
  • Stock Information
  • Founded
  • RIGL 1996
  • HRTX 1983
  • Country
  • RIGL United States
  • HRTX United States
  • Employees
  • RIGL N/A
  • HRTX N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RIGL Health Care
  • HRTX Health Care
  • Exchange
  • RIGL Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • RIGL 335.5M
  • HRTX 325.0M
  • IPO Year
  • RIGL 2000
  • HRTX 1987
  • Fundamental
  • Price
  • RIGL $20.97
  • HRTX $2.00
  • Analyst Decision
  • RIGL Buy
  • HRTX Strong Buy
  • Analyst Count
  • RIGL 5
  • HRTX 2
  • Target Price
  • RIGL $36.40
  • HRTX $5.50
  • AVG Volume (30 Days)
  • RIGL 217.1K
  • HRTX 1.3M
  • Earning Date
  • RIGL 08-05-2025
  • HRTX 05-06-2025
  • Dividend Yield
  • RIGL N/A
  • HRTX N/A
  • EPS Growth
  • RIGL N/A
  • HRTX N/A
  • EPS
  • RIGL 2.08
  • HRTX N/A
  • Revenue
  • RIGL $203,077,000.00
  • HRTX $148,518,000.00
  • Revenue This Year
  • RIGL $14.41
  • HRTX $12.60
  • Revenue Next Year
  • RIGL $15.97
  • HRTX $13.66
  • P/E Ratio
  • RIGL $10.14
  • HRTX N/A
  • Revenue Growth
  • RIGL 70.16
  • HRTX 12.43
  • 52 Week Low
  • RIGL $7.48
  • HRTX $1.04
  • 52 Week High
  • RIGL $29.82
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 61.71
  • HRTX 50.55
  • Support Level
  • RIGL $18.63
  • HRTX $1.82
  • Resistance Level
  • RIGL $20.99
  • HRTX $1.93
  • Average True Range (ATR)
  • RIGL 1.07
  • HRTX 0.09
  • MACD
  • RIGL 0.11
  • HRTX 0.02
  • Stochastic Oscillator
  • RIGL 82.81
  • HRTX 75.00

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: